Thoracic epidural anesthesia and left cardiac sympathetic denervation decreased arrhythmia burden in 75% and 56% of patients with refractory ventricular tachycardia, respectively.
Observational (n=14)
Does neuraxial modulation (thoracic epidural anesthesia and left cardiac sympathetic denervation) reduce ventricular arrhythmia burden in patients with refractory VT and structural heart disease?
Thoracic epidural anesthesia and left cardiac sympathetic denervation may be effective adjunctive therapies or bridges to definitive treatment for refractory ventricular arrhythmias in patients with structural heart disease.
BACKGROUND: Reducing sympathetic output to the heart from the neuraxis can protect against ventricular arrhythmias. The purpose of this study was to assess the value of thoracic epidural anesthesia (TEA) and left cardiac sympathetic denervation (LCSD) in the management of ventricular arrhythmias in patients with structural heart disease. METHODS AND RESULTS: Clinical data of 14 patients (25 to 75 years old, mean+/-SD of 54.2+/-16.6 years; 13 men) who underwent TEA, LCSD, or both to control ventricular tachycardia (VT) refractory to medical therapy and catheter ablation were reviewed. Twelve patients were in VT storm, and 2 experienced recurrent VT despite maximal medical therapy and catheter ablation procedures. The total number of therapies per patient before either procedure ranged from 5 to 202 (median of 24; 25th and 75th percentile, 5 and 56). Eight patients underwent TEA, and 9 underwent LCSD (3 patients had both procedures). No major procedural complications occurred. After initiation of TEA, 6 patients had a large (> or =80%) decrease in VT burden. After LCSD, 3 patients had no further VT, 2 had recurrent VT that either resolved within 24 hours or responded to catheter ablation, and 4 continued to have recurrent VT. Nine of 14 patients survived to hospital discharge (2 TEA alone, 3 TEA/LCSD combined, and 4 LCSD alone), 1 of the TEA alone patients underwent an urgent cardiac transplantation. CONCLUSIONS: Initiation of TEA and LCSD in patients with refractory VT was associated with a subsequent decrease in arrhythmia burden in 6 (75%) of 8 patients (68% confidence interval 51% to 91%) and 5 (56%) of 9 patients (68% confidence interval 34% to 75%), respectively. These data suggest that TEA and LCSD may be effective additions to the management of refractory ventricular arrhythmias in structural heart disease when other treatment modalities have failed or may serve as a bridge to more definitive therapy.
Bourke et al. (Mon,) conducted a observational in Refractory ventricular arrhythmias (n=14). Thoracic epidural anesthesia (TEA) and left cardiac sympathetic denervation (LCSD) was evaluated on Decrease in arrhythmia burden. Thoracic epidural anesthesia and left cardiac sympathetic denervation decreased arrhythmia burden in 75% and 56% of patients with refractory ventricular tachycardia, respectively.